Genetic recombination is believed to assist HIV-1 diversification and escape from host immunity
and antiviral therapies, yet this process remains largely unexamined within the natural …

High-level immune activation and T cell apoptosis represent a hallmark of HIV-1 infection
that is absent from nonpathogenic SIV infections in natural primate hosts. The mechanisms …

Ongoing observational clinical research has prioritized understanding the human immune
response to SARS-CoV-2 during the coronavirus disease 2019 (COVID-19) pandemic. …

The ability of human immunodeficiency virus type 1 (HIV-1) to establish latent infections in
cells has received renewed attention owing to the failure of highly active antiretroviral therapy …

Following integration, HIV-1 in most cases produces active infection events; however, in
some rare instances, latent infection events are established. The latter have major clinical …

Tuberculosis is a severe disease affecting millions worldwide. Unfortunately, treatment
strategies are hampered both by the prohibitively long treatment regimen and the rise of drug-…

Recent research has emphasized the notion that human immunodeficiency virus type 1 (HIV-1)
latency is controlled by a restrictive histone code at, or DNA methylation of, the integrated …

HIV-1 replication within macrophages of the CNS often results in cognitive and motor
impairment, which is known as HIV-associated dementia (HAD) in its most severe form. IFN-β …

Chemokines constitute a superfamily of proteins that function as chemoattractants and
activators of leukocytes. Astrocytes, the major glial cell type in the CNS, are a source of …

Copper (Cu) ions are likely the most important immunological metal-related toxin utilized in
controlling bacterial infections. Impairment of bacterial Cu resistance reduces viability within …